GSK Supply Status
At this time, COVID-19 is not having an impact on GSK supply in the UK.
Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler
Product name |
PIP Code |
Status |
Estimated recovery date |
---|---|---|---|
AUGMENTIN PDR/SUSP 457MG 1X35ML_UK | 4101630 | OUT OF STOCK | MID MARCH 2023 |
AUGMENTIN SUSP 250/62.5MG/5ML 1X100ML_UK | 823609 | OUT OF STOCK | EARLY FEBRUARY 2023 |
AUGMENTIN TABLET 375MG 3X7_GB | 457374 | OUT OF STOCK | MID FEBRUARY 2023 |
BACTROBAN OINT 2% TUBE 15G X 1 UK-GSK | 29769 | OUT OF STOCK | EARLY FEBRUARY 2023 |
BETNOVATE CRM 0.1% 30G UK-GSK | 29447 | OUT OF STOCK | MID MARCH 2023 |
BETNOVATE OINTMENT 0.1% 1X30G_UK-GSK | 29488 | OUT OF STOCK | LATE FEBRUARY 2023 |
BETNOVATE RD OINT 0.025% 100G UK-GSK | 485227 | OUT OF STOCK | EARLY FEBRUARY 2023 |
DARAPRIM TAB 25MG BLISTER 30S - UK | 68999 | OUT OF STOCK | LATE FEBRUARY 2023 |
DUAC LOW DOSE GEL 3/1% 1X30G_UK-GSK | 3808276 | OUT OF STOCK | EARLY FEBRUARY 2023 |
EUMOVATE CRM 0.05% 100G UK-GSK | 483503 | OUT OF STOCK | MID FEBRUARY 2023 |
EUMOVATE OINT 0.05% 100G UK-GSK | 29827 | OUT OF STOCK | MID FEBRUARY 2023 |
EUMOVATE OINT 0.05% 30G UK-GSK | 143214 | OUT OF STOCK | EARLY FEBRUARY 2023 |
INTEGRILIN INJ 2MG/ML10ML UK-GSK | 2640688 | OUT OF STOCK | EARLY FEBRUARY 2023 |
LAMICTAL CD TABLET 2MG 1X30 | 2710804 | OUT OF STOCK | LATE FEBRUARY 2023 |
LAMICTAL DISPERSIBLE TABLET 5MG 1X30 | 4172326 | OUT OF STOCK | EARLY FEBRUARY 2023 |
VOLUMATIC PAED 1X1 | 978981 | OUT OF STOCK | MID FEBRUARY 2023 |
ZOVIRAX CREAM 5% TUBE 2GX1 UK-GSK | 402040 | OUT OF STOCK | LATE FEBRUARY 2023 |
ZYBAN TAB 150MG 6X10_GB | 2709848 | OUT OF STOCK | TBC |
Product Name |
Pip code |
Status |
Estimated Recovery Date |
---|---|---|---|
HAVRIX.720 CCT +1N AFS GB | 2874592 | Limited Availability | Late January 2023 |
HAVRIX.720 CCT X10 +10N CT AFS GB | 2874600 | Limited Availability | Late January 2023 |
TWIN.PED CCT +1N FS GB | 2421899 | Limited Availability | Mid March 2023 |
If you have any queries about the availability of a product, please contact your wholesaler.
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.